U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 22:25:51 GMT 2025
Edited
by admin
on Tue Apr 01 22:25:51 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
VFH55IZ5VI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TTAC-0001
Preferred Name English
OLINVACIMAB
INN  
Official Name English
Olinvacimab [WHO-DD]
Common Name English
olinvacimab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL TTAC-0001 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TTAC-0001 LIGHT CHAIN, DIMER
Common Name English
FULLY HUMAN MONOCLONAL ANTIBODY TARGETS VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
Common Name English
TANIBIRUMAB
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 628118
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
NCI_THESAURUS C93170
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
Code System Code Type Description
INN
10829
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
PRIMARY
CAS
1338824-06-8
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
NO STRUCTURE GIVEN
NCI_THESAURUS
C102877
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
PRIMARY
SMS_ID
100000183533
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
PRIMARY
FDA UNII
VFH55IZ5VI
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
PRIMARY
CAS
2095504-49-5
Created by admin on Tue Apr 01 22:25:51 GMT 2025 , Edited by admin on Tue Apr 01 22:25:51 GMT 2025
PRIMARY
From To
1_28 1_102
1_159 1_215
1_276 1_336
1_382 1_440
1_241 2_241
1_244 2_244
1_235 3_227
2_28 2_102
2_159 2_215
2_276 2_336
2_382 2_440
2_235 4_227
3_27 3_92
3_147 3_207
4_27 4_92
4_147 4_207
Glycosylation Link Type Site
N 1_312
N 2_312
Related Record Type Details
OLINVACIMAB
ACTIVE MOIETY
immunomodulator, antineoplastic
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966